| Video
Dr. Martin Cheatle, Associate Professor at the University of Pennsylvania’s Perelman School of Medicine, offers his opinion on medications used to treat opioid use disorder: methadone, buprenorphine, and naltrexone.
| Article
As stated in the abstract of an article in JCO Clinical Cancer Informatics, a journal of the American Society of Clinical Oncology, “Approximately 40% of childhood cancer survivors experience chronic pain, with many also reporting pain-related disability. Given associations established in the...
| Article
A study reported in the journal Sleep posits that adolescents who experience sleep deficiency may develop into adults who misuse prescription opioids. The study, the self-reported National Longitudinal Study of Adolescent to Adult Health followed >12,000 participants over the course of 12 years...
| Article
The Journal of Rheumatology reports a concerning increase in hospitalizations for opioid use disorder (OUD) in patients with musculoskeletal conditions. Comparing data from 1998-2000 vs 2015-2016, OUD hospitalization rates for gout, osteoarthritis, fibromyalgia, rheumatoid arthritis, and low back...
| Article
An article in Substance Use and Addiction asks, “Are medication monitoring programs within a hospital associated with more accurate identification of patients with opioid use disorder through the use of proxy Diagnostic and Statistical Manual of Mental Disorders criteria for opioid use disorder...
| Podcast
Opioid use and addiction have soared in the United States over the past 20 years, and drug overdoses have become the leading cause of injury death.
Persons with opioid use disorder (OUD), particularly those injecting opioids, frequently require hospitalization and encounter need of acute opioid...
| Article
In research presented today by the American Chemical Society (ACS), it is stated that long term opioid use can lead to chronic inflammation and heightened pain sensitivity. Why? Study leader Cody J. Wenthur, PharmD, PhD, commented, “…we started thinking that the patient’s own immune system could be...
| Article
The American Medical Association just released a new OPIOID TASK FORCE 2020 PROGRESS REPORT in the hopes of reducing drug overdoses and deaths. Although prescription opioid overdose deaths have decreased, illicit drugs such as heroin, methamphetamine, and cocaine have risen. Last year, fentanyl...
| Article
“Even during this global pandemic, we have continued to prioritize addressing the opioid crisis,” says Stephen M. Hahn, MD, the FDA’s Commissioner, referring to the FDA’s new labeling requirement. This labeling—on opioid pain medication and opioid use disorder medication—must include the...
| Article
Abuse deterrent formulations: different manners of preventing someone from transgressing to the inhalation or snorting of medications, or intravenous use.
- Aversion: if someone attempts to abuse the product it would not feel good. For instance, if the product is crushed and snorted, the nose is...